The Multi - Factorial Equations of ART (Assisted Reproductive Technology): Defining and Maximizing Success in Pregnancy Rates

SORRENTO, Italy, May 18, 2012 /PRNewswire/ --

Serono Symposia International Foundation (SSIF) will gather a team of leading international experts in infertility and reproductive medicine on May 18 - 19 in Sorrento in order to attend the symposium entitled "The Multi - factorial equations of ART (Assisted Reproductive Technology): defining and maximizing success in pregnancy rates". Peter Zsolt Nagy - from the Reproductive Biology Associates Assisted Fertilization Technology, Atlanta Usa - and Filippo Maria Ubaldi from the Centre for Reproductive Medicine G.E.N.E.R.A, Rome, Italy are the scientific organizers of the event.

     (Logo: http://www.newscom.com/cgi-bin/prnh/20100629/397361)

"The most important aim of this meeting is to bring the latest knowledge on ART to the audience," said Peter Zsolt Nagy, "and to provide practical approaches on how to implement the most modern diagnostic and therapeutic options when treating infertility."

This symposium will analyze some of the potential clinical and embryological variables to apply, as well as the most precise way to define and maximise success in ART. Experts in the field of reproductive medicine agree that in order to achieve success, one must take into account that each variable involved in the system must be managed and controlled to secure that the ideal treatment is identified and tailor made  for each patient.

"After more than 30 years of application of ART technologies, the real efficacy of IVF remains still low," said Filippo Maria Ubaldi, "and it has been recently demonstrated that only about 5% of inseminated oocytes give rise to the delivery of a healthy baby. This is mainly due to the intrinsic quality of the gametes used (especially oocytes) that are generally poorly competent from a developmental and a genetical point of view in the ART patient population, but we do believe that modern technologies could change this figure."

"As Continuing Medical Education Partner, SSIF is committed to offer its know-how in an international scenario," said Michèle Piraux, "Secretary to the Board of Directors of SSIF - and we are particularly proud to be able to bring together in this scenario the leaders of reproductive medicine in order to define and maximase success in ART." SSIF is a non-profit organization based in Geneva (Switzerland). It was founded to disseminate the most innovative achievements and potential developments of medical and scientific research through Continuing Medical Education (CME) programs to improve the patient's life.